Atlas Arteria Limited Stock Performance
| MAQAF Stock | USD 3.10 0.00 0.00% |
On a scale of 0 to 100, Atlas Arteria holds a performance score of 2. The firm shows a Beta (market volatility) of 0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Atlas Arteria's returns are expected to increase less than the market. However, during the bear market, the loss of holding Atlas Arteria is expected to be smaller as well. Please check Atlas Arteria's total risk alpha, downside variance, day median price, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Atlas Arteria's price patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Atlas Arteria Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Atlas Arteria reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 260.3 M |
Atlas |
Atlas Arteria Relative Risk vs. Return Landscape
If you would invest 302.00 in Atlas Arteria Limited on December 12, 2024 and sell it today you would earn a total of 8.00 from holding Atlas Arteria Limited or generate 2.65% return on investment over 90 days. Atlas Arteria Limited is currently producing 0.2297% returns and takes up 6.0435% volatility of returns over 90 trading days. Put another way, 53% of traded pink sheets are less volatile than Atlas, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Atlas Arteria Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atlas Arteria's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Atlas Arteria Limited, and traders can use it to determine the average amount a Atlas Arteria's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.038
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MAQAF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.04 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Atlas Arteria is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atlas Arteria by adding it to a well-diversified portfolio.
Atlas Arteria Fundamentals Growth
Atlas Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Atlas Arteria, and Atlas Arteria fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atlas Pink Sheet performance.
| Return On Equity | 0.0695 | |||
| Return On Asset | -0.0025 | |||
| Profit Margin | 2.33 % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 7.66 B | |||
| Shares Outstanding | 1.45 B | |||
| Price To Earning | 29.15 X | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 60.77 X | |||
| Revenue | 99.53 M | |||
| EBITDA | 320.76 M | |||
| Cash And Equivalents | 196.75 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 1.53 B | |||
| Debt To Equity | 0.48 % | |||
| Book Value Per Share | 3.54 X | |||
| Cash Flow From Operations | 57.39 M | |||
| Earnings Per Share | 0.14 X | |||
| Total Asset | 5.22 B | |||
| Retained Earnings | (684 M) | |||
| Current Asset | 222 M | |||
| Current Liabilities | 80 M | |||
About Atlas Arteria Performance
By analyzing Atlas Arteria's fundamental ratios, stakeholders can gain valuable insights into Atlas Arteria's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Atlas Arteria has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Atlas Arteria has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Atlas Arteria Limited owns, develops, and operates toll roads. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia. Macquarie Atlas operates under Infrastructure Operations classification in the United States and is traded on OTC Exchange.Things to note about Atlas Arteria Limited performance evaluation
Checking the ongoing alerts about Atlas Arteria for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Atlas Arteria Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Atlas Arteria had very high historical volatility over the last 90 days | |
| About 18.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Atlas Arteria's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atlas Arteria's stock is overvalued or undervalued compared to its peers.
- Examining Atlas Arteria's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Atlas Arteria's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atlas Arteria's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Atlas Arteria's pink sheet. These opinions can provide insight into Atlas Arteria's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Atlas Pink Sheet analysis
When running Atlas Arteria's price analysis, check to measure Atlas Arteria's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atlas Arteria is operating at the current time. Most of Atlas Arteria's value examination focuses on studying past and present price action to predict the probability of Atlas Arteria's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atlas Arteria's price. Additionally, you may evaluate how the addition of Atlas Arteria to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |